Bulletin from the extraordinary general meeting of Calliditas Therapeutics AB (publ)

The following resolutions were passed at Calliditas Therapeutics AB (publ) (“Calliditas”) extraordinary general meeting held today, on 30 September 2024, in

READ MORE

Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm

Nasdaq Stockholm has decided that Calliditas Therapeutics AB (publ) will be delisted from Nasdaq Stockholm. The last day of trading

READ MORE